MDKA Stock Overview
Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia.
Notes are coming soon
Medika d.d. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€4,100.00|
|52 Week High||€4,174.94|
|52 Week Low||€3,569.63|
|1 Month Change||5.07%|
|3 Month Change||n/a|
|1 Year Change||2.87%|
|3 Year Change||75.67%|
|5 Year Change||94.50%|
|Change since IPO||283.56%|
Recent News & Updates
|MDKA||HR Healthcare||HR Market|
Return vs Industry: MDKA exceeded the HR Healthcare industry which returned -26.6% over the past year.
Return vs Market: MDKA exceeded the HR Market which returned 0.1% over the past year.
|MDKA Average Weekly Movement||n/a|
|Healthcare Industry Average Movement||4.6%|
|Market Average Movement||4.2%|
|10% most volatile stocks in HR Market||8.0%|
|10% least volatile stocks in HR Market||2.7%|
Stable Share Price: Insufficient data to determine MDKA's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine MDKA's volatility change over the past year.
About the Company
Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. The company primarily sells, stores, and distributes human and veterinary drugs, medicinal products, equipment and dental supplies, dietetic, cosmetic, hygienic, and other products. It serves pharmacies, healthcare facilities, hospitals, health centers, outpatient facilities, doctor’s offices, wholesalers, and specialized stores; and dental practices, veterinary clinics, and medical centers, as well as herbal pharmacies, companies, optics, and others.
Medika d.d. Fundamentals Summary
|MDKA fundamental statistics|
Is MDKA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MDKA income statement (TTM)|
|Cost of Revenue||Kn4.19b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||4.23k|
|Net Profit Margin||2.69%|
How did MDKA perform over the long term?See historical performance and comparison